ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2021, 'Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors', Alzheimer's and Dementia: Translational Research and Clinical Interventions, 7, pp. e12202, http://dx.doi.org/10.1002/trc2.12202
,2021, 'Effects of intensive blood pressure treatment on orthostatic hypotension a systematic review and individual participant-based meta-analysis', Annals of Internal Medicine, 174, pp. 58 - 68, http://dx.doi.org/10.7326/M20-4298
,2021, 'Gender Differences in Cognitive Development in Cohorts of Young, Middle, and Older Adulthood Over 12 Years', Developmental Psychology, 57, pp. 1403 - 1410, http://dx.doi.org/10.1037/dev0001210
,2020, 'What does (low) education mean in terms of dementia risk? A systematic review and meta-analysis highlighting inconsistency in measuring and operationalising education', SSM - Population Health, 12, pp. 100654, http://dx.doi.org/10.1016/j.ssmph.2020.100654
,2020, 'Effects Of Intensive Blood Pressure Treatment On Orthostatic Hypotension: An Individual-level Meta-analysis.', HYPERTENSION, 76, http://dx.doi.org/10.1161/hyp.76.suppl_1.MP36
,2020, 'Atrial fibrillation and the risk of cardiovascular disease and mortality in the Hypertension in the Very Elderly Trial', Journal of Hypertension, 38, pp. 839 - 844, http://dx.doi.org/10.1097/HJH.0000000000002346
,2020, 'Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta-analysis consisting 2.8 million adults with 57 294 cases of dementia', Obesity Reviews, 21, pp. e12989, http://dx.doi.org/10.1111/obr.12989
,2020, 'Association Between Blood Pressure Variability and Cerebral Small-Vessel Disease: A Systematic Review and Meta-Analysis', Journal of the American Heart Association, 9, pp. e013841, http://dx.doi.org/10.1161/JAHA.119.013841
,2020, 'Advancing dementia prevention through effective blood pressure control', The Lancet Neurology, 19, pp. 25 - 27, http://dx.doi.org/10.1016/S1474-4422(19)30407-7
,2020, 'Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?', Brain Communications, 2, pp. fcaa109, http://dx.doi.org/10.1093/braincomms/fcaa109
,2020, 'Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus', Journal of Alzheimer's Disease, 78, pp. 3 - 12, http://dx.doi.org/10.3233/JAD-200674
,2020, 'Trajectory of blood pressure, body mass index, cholesterol and incident dementia: Systematic review', British Journal of Psychiatry, 216, pp. 16 - 28, http://dx.doi.org/10.1192/bjp.2019.156
,2020, 'An investigation of antihypertensive class, dementia, and cognitive decline', Neurology, 94, pp. 1 - 15, http://dx.doi.org/10.1212/wnl.0000000000008732
,2020, 'Dementia Risk Reduction in Practice: The Knowledge, Opinions and Perspectives of Australian Healthcare Providers', , http://dx.doi.org/10.1101/2020.07.01.20144550
,2019, 'Blood pressure and dementia: What the SPRINT-MIND trial adds and what we still need to know', Neurology, 92, pp. 1017 - 1018, http://dx.doi.org/10.1212/WNL.0000000000007543
,2019, 'Subjective memory complaints and incident dementia in a high risk older adult hypertensive population', Age and Ageing, 48, pp. 253 - 259, http://dx.doi.org/10.1093/ageing/afy193
,2019, 'Exploiting Drug-Apolipoprotein E Gene Interactions in Hypertension to Preserve Cognitive Function: The 3-City Cohort Study', Journal of the American Medical Directors Association, 20, pp. 188 - 194.e4, http://dx.doi.org/10.1016/j.jamda.2018.08.002
,2019, 'A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence', Journal of Alzheimer's Disease, 70, pp. S165 - S186, http://dx.doi.org/10.3233/JAD-190181
,2019, 'Air Pollution and Dementia: A Systematic Review', Journal of Alzheimer's Disease, 70, pp. S145 - S163, http://dx.doi.org/10.3233/JAD-180631
,2019, 'Combining modifiable risk factors and risk of dementia: A systematic review and meta-analysis', BMJ Open, 9, pp. bmjopen-2018-022846, http://dx.doi.org/10.1136/bmjopen-2018-022846
,2019, 'Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction', Therapeutic Advances in Chronic Disease, 10, http://dx.doi.org/10.1177/2040622319880392
,2019, 'Dementia, Risk, Risk Reduction, and Translation into Practice: An International Research Network for Dementia Prevention (IRNDP) Special Issue', Journal of Alzheimer's Disease, 70, pp. S1 - S3, http://dx.doi.org/10.3233/JAD-190506
,2019, 'No clear relationship between antihypertensive class and cognitive function over 12 months in a cohort study of community-dwelling adults aged 80 and over', Therapeutic Advances in Chronic Disease, 10, pp. 2040622318820849, http://dx.doi.org/10.1177/2040622318820849
,2019, 'P3‐599: LIMITED GLOBAL REPRESENTATIVENESS OF EVIDENCE ON RISK FACTORS FOR DEMENTIA: A CHALLENGE FOR DEVELOPING RISK REDUCTION GUIDELINES', Alzheimer's & Dementia, 15, pp. p1205 - p1206, http://dx.doi.org/10.1016/j.jalz.2019.06.3636
,2018, 'More evidence is needed. Iron, incident cognitive decline and dementia: a systematic review', Therapeutic Advances in Chronic Disease, 9, pp. 241 - 256, http://dx.doi.org/10.1177/2040622318788485
,2018, 'Alcohol and dementia — risk or protective factor?', Nature Reviews Neurology, 14, pp. 635 - 636, http://dx.doi.org/10.1038/s41582-018-0073-0
,2018, 'The association between blood pressure variability (BPV) with dementia and cognitive function: a systematic review and meta-analysis protocol', Systematic Reviews, 7, pp. 163, http://dx.doi.org/10.1186/s13643-018-0811-9
,2018, 'Effect of SSRI and calcium channel blockers on depression symptoms and cognitive function in elderly persons treated for hypertension: Three city cohort study', International Psychogeriatrics, 30, pp. 1345 - 1354, http://dx.doi.org/10.1017/S1041610217002903
,2018, 'Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: An integrated evidence review and analysis of a large older adult hypertensive cohort', European Heart Journal, 39, pp. 3135 - 3143, http://dx.doi.org/10.1093/eurheartj/ehy418
,2018, 'Greater cognitive decline relative to normal ageing occurs at least 10 years prior to clinical dementia diagnosis', Evidence-Based Medicine, 23, pp. 79 - 80, http://dx.doi.org/10.1136/bmjebm-2017-110876
,2018, 'oversimplification of dementia risk reduction messaging is a threat to knowledge translation in dementia prevention research', The journal of prevention of Alzheimer's disease, 5, pp. 2 - 4, http://dx.doi.org/10.14283/jpad.2017.27
,2018, 'P3‐589: HIGH URIC ACID ASSOCIATED WITH REDUCED RISK OF COGNITIVE DECLINE IN HYPERTENSIVE OLDER ADULTS', Alzheimer's & Dementia, 14, http://dx.doi.org/10.1016/j.jalz.2018.06.1955
,2018, 'Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study', Alzheimer's and Dementia, 14, pp. 280 - 292, http://dx.doi.org/10.1016/j.jalz.2017.09.007
,2017, 'Joining forces to prevent dementia: The International Research Network on Dementia Prevention (IRNDP)', International Psychogeriatrics, 29, pp. 1757 - 1760, http://dx.doi.org/10.1017/S1041610217001685
,2017, 'Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: A systematic review and meta-analysis', JAMA Internal Medicine, 177, pp. 1498 - 1505, http://dx.doi.org/10.1001/jamainternmed.2017.4377
,2017, 'The Vascular Impairment of Cognition Classification Consensus Study', Alzheimer's and Dementia, 13, pp. 624 - 633, http://dx.doi.org/10.1016/j.jalz.2016.10.007
,2017, 'Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly Trial', Blood Pressure, 26, pp. 109 - 114, http://dx.doi.org/10.1080/08037051.2016.1219222
,2017, 'Updating the evidence on the association between serum cholesterol and risk of late-life dementia: Review and meta-analysis', Journal of Alzheimer's Disease, 56, pp. 215 - 228, http://dx.doi.org/10.3233/JAD-160826
,2016, 'Corrigendum: 'The risk of overweight/obesity in mid-life and late life for the development of dementia: A systematic review and meta-analysis of longitudinal studies' [Age and Ageing, 45, (2016), (14)]. doi: 10.1093/ageing/afv151', Age and Ageing, 45, pp. 737 - 738, http://dx.doi.org/10.1093/ageing/afw095
,2016, 'Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials', Current Hypertension Reports, 18, pp. 67, http://dx.doi.org/10.1007/s11906-016-0674-1
,2016, 'Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies', Current Hypertension Reports, 18, http://dx.doi.org/10.1007/s11906-016-0673-2
,2016, 'Literature review of visual representation of the results of benefit-risk assessments of medicinal products', Pharmacoepidemiology and Drug Safety, 25, pp. 238 - 250, http://dx.doi.org/10.1002/pds.3880
,2016, 'Type 2diabetes as a risk factor for dementia in women compared with men: A pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia', Diabetes Care, 39, pp. 300 - 307, http://dx.doi.org/10.2337/dc15-1588
,2016, 'Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial', Journal of Hypertension, 34, pp. 2280 - 2286, http://dx.doi.org/10.1097/HJH.0000000000001073
,2016, 'The risk of overweight/obesity in mid-life and late life for the development of dementia: A systematic review and meta-analysis of longitudinal studies', Age and Ageing, 45, pp. 14 - 21, http://dx.doi.org/10.1093/ageing/afv151
,2015, 'Is air pollution associated with increased risk of cognitive decline? A systematic review', Age and Ageing, 44, pp. 755 - 760, http://dx.doi.org/10.1093/ageing/afv087
,2015, 'No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: An investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over', BMC Medicine, 13, http://dx.doi.org/10.1186/s12916-015-0328-1
,2015, 'The clock drawing test, mortality, incident cardiovascular events and dementia', International Journal of Geriatric Psychiatry, 30, pp. 416 - 421, http://dx.doi.org/10.1002/gps.4153
,2015, 'Antihypertensive drug use and risk of cognitive decline in the very old: An observational study - The Newcastle 85+ Study', Journal of Hypertension, 33, pp. 2156 - 2164, http://dx.doi.org/10.1097/HJH.0000000000000653
,2015, 'Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: A systematic review', Therapeutic Advances in Chronic Disease, 6, pp. 160 - 169, http://dx.doi.org/10.1177/2040622315582353
,